NIH has just announced a significant change in its policy for resubmission applications.
Effective immediately, for application due dates after April 16, 2014, following an unsuccessful resubmission (A1) application, applicants may submit the same idea as a new (A0) application for the next appropriate due date. NIH will not assess the similarity of the science in the new (A0) application to any previously reviewed submission when accepting an application for review.
NIH’s policy for accepting overlapping applications remains in effect (see NOT-OD-09-100), so it will not accept duplicate or highly overlapping applications under review at the same time. This means that NIH will not review:
- A new (A0) application that is submitted before issuance of the summary statement from the review of an overlapping resubmission (A1) application.
- A resubmission (A1) application that is submitted before issuance of the summary statement from the review of the previous new (A0) application.
- An application that has substantial overlap with another application pending appeal of initial peer review (see NOT-OD-11-101).
The NIH time limit for accepting resubmission (A1) applications remains in effect, as well (see NOT-OD-12-128 and NOT-OD-10-140). NIH will not accept a resubmission (A1) application that is submitted later than 37 months after submission of the new (A0) application that it follows.
Also remaining in effect is the NIH policy for new investigator R01 resubmission deadlines, described in NOT-OD-11-057.
Background and details on the new resubmission policy are in NIH Guide NOT-OD-14-074 and a blog post by NIH’s Sally Rockey.
Earlier this year, I told you about the formation of two committees focused on Protein Structure Initiative (PSI) transition planning. These committees are charged with determining what unique resources and capabilities developed during the PSI should be preserved after the initiative ends and how this preservation should be done.
An important part of this process is getting input from the community, so we have just issued a request for information (RFI), NOT-GM-14-115, seeking comments about structural biology resources that have a high impact on the community, whether those resources have been supported through the PSI or by other means. We also want to hear what you think about the future of structural biology-related technology development, which has been an important feature of the PSI.
While the RFI invites comments on these specific topics, you should not feel limited to them—we welcome any comments that you feel are relevant.
To respond to the RFI, send an e-mail to email@example.com by May 23, 2014. When we compile the responses, we’ll remove any personal identifiers like names and e-mail addresses and only use de-identified comments.
If you have any questions about the RFI or the transition committees, please let me know.
As part of our efforts to develop and sustain a highly skilled and diverse biomedical research workforce, we have introduced a new mechanism to complement or enhance research training activities. The Innovative Programs to Enhance Research Training (IPERT) will support creative and innovative research educational activities through courses for skills development, structured mentoring activities and outreach programs.
We expect the scope, purpose and objectives of IPERT applications to be as varied as the potential applicants. Both institutions and organizations are eligible to apply.
An IPERT program should address a documented need, problem or challenge in research training and include measurable goals and objectives. Applications should explain the balance of effort and resources dedicated to each activity and how the activities will integrate. Proposals should also align with the NIGMS Strategic Plan for Biomedical and Behavioral Research Training, which recognizes that:
- Research training is a responsibility shared by NIH, academic institutions, faculty and trainees.
- Research training must focus on student development, not simply the selection of talent.
- Breadth and flexibility enable research training to keep pace with the opportunities and demands of contemporary science and provide the foundation for a variety of scientific career paths.
- Diversity is an indispensable component of research training excellence and must be advanced across the entire research enterprise.
The IPERT program may be of particular interest to institutions and organizations with current or past support from the MARC Ancillary Training Activities program (T36), which has lapsed and will not be reissued. Conference and meeting programs previously supported by the T36 mechanism may be more appropriately supported through the NIH conference grant mechanism (R13/U13).
While a letter of intent is not required, we strongly encourage anyone who is interested in submitting an IPERT application to consult with me or other staff of the NIGMS Division of Training, Workforce Development, and Diversity to determine if this is the best mechanism to support their ideas and plans.
NIGMS grantees have one final opportunity to introduce new collaborations into their ongoing research projects through the Supplements for Collaborative Science (SCS) program. The submission deadline in response to NOT-GM-11-105 is May15, 2014. Investigators can request supplements of up to $90,000 per year in direct costs for two collaborating labs or up to $135,000 per year for three collaborating labs.
The proposed research must be within the original scope of the project and should propose approaches not used previously by the principal investigator. All collaborators should be able to make significant intellectual contributions, and we especially encourage proposals that involve less commonly combined areas of expertise.
To be eligible, an NIGMS parent R01 or R37 award must be actively funded through November 30, 2015. Proposals may request support to cover a period up to the end of the parent project. The application now requires that collaborating investigators provide a letter of commitment and “other support” page countersigned by their institutional official. Send any additional questions to me at firstname.lastname@example.org or to Sue Haynes at email@example.com.
The SCS program is very competitive, so if you are interested in submitting an application, we recommend that you first discuss your potential proposal—and its new and novel aspects—with the program director of your grant.
You may be interested in the following funding opportunity announcements:
Big Data Science
Purpose: Research and develop new technologies in biomedical computing, informatics and big data science that will support rapid progress in biomedical research
- Early Stage Development of Technologies in Biomedical Computing, Informatics, and Big Data Science (R43/R44)
- Early Stage Development of Technologies in Biomedical Computing, Informatics, and Big Data Science (R01)
- Extended Development, Hardening and Dissemination of Technologies in Biomedical Computing, Informatics, and Big Data Science (R01)
- Early Stage Development of Technologies in Biomedical Computing, Informatics, and Big Data Science (R41/R42)
Application due dates: Standard dates apply
NIGMS contact: Peter Lyster, 301-451-6446
Initiative for Maximizing Student Development (IMSD) (R25)
Purpose: Develop new or expand existing institutional developmental programs at research-intensive institutions that prepare undergraduate and graduate students from diverse backgrounds for attaining the Ph.D. degree in biomedical or behavioral sciences and subsequent competitive research careers and leadership positions
Application due dates: May 1, 2014; January 26, 2015; January 25, 2016
NIGMS contact: Daniel Janes, 301-594-0943
Each year, an average of 65 NIGMS-funded principal investigators move to new universities or other institutions. With everything else they need to do, they sometimes neglect to consider how the move will affect their grants, or they start the process too late. When they try to hire staff or purchase supplies in the new location, they may discover that grant funds are not available. Remember that your grant is made to an institution, so you will need to involve your current and your new institutions early on to make sure that your transition is smooth.
You also need to be in touch with NIGMS staff early, allowing enough time for us to review any move-related change that requires NIH approval and, if approved, process it. When you begin plans to change institutions, contact your NIGMS program director and grants management specialist to discuss the timing of your move, options for managing your grant through the transition and the possible impact of the transfer on your research. Some situations don’t require the transfer of your grant at all. NIGMS staff can help you find the right solution for your circumstances, including the management of consortium arrangements and the involvement of animals or human subjects.
If you do want to transfer a grant to a new organization, you should contact NIGMS staff well before the anticipated start date at the new institution. Both your former institution and your new one will need to submit information to us before the grant can be moved and you can draw funds. We recommend providing all required materials at least 3 months in advance of the move.
Here are some NIH resources on transferring grants:
PA-14-078 Change of Grantee Institution (Type 7 Parent)
NIH Grants Policy Statement, Section 188.8.131.52 Change of Grantee Organization